Evidence map›Paper›PMID 42948390›Full record

ArticleChinese herbal medicines2026

HXZQCG: A database of natural diverse components in polyherbal formulation HXZQ identified naringenin chalcone as a ligand of H

Shengjie You, Jing Mo, Guoqing Xu, Zhuangyuan Xie, Wenke Xiao, Guiyang Zhang, Yufei Mao, Qi Shen, Leu Kim Fey, Sanyin Zhang and 3 more

Abstract read
In one paragraph

Article in Chinese herbal medicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shengjie YouInnovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Jing MoInnovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Guoqing XuInnovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Zhuangyuan XieInnovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Wenke XiaoInstitute of Herbgenomics, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Guiyang ZhangInstitute of Herbgenomics, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Yufei MaoInstitute of Herbgenomics, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Qi ShenInstitute of Medical Plant Physiology and Ecology, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Leu Kim FeyM. Kandiah Faculty of Medicine and Health Sciences, University Tunku Abdul Rahman, Perak 31900, Malaysia.
Sanyin ZhangInnovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Wei ChenInnovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Liang LengInnovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Fanbo MengInnovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Huoxiang Zhengqi (HXZQ) is a classical polyherbal formulation used to treat gastrointestinal disorders. It exerts multi-targeted therapeutic effects, yet its phytochemical complexity hinders standardization and modern pharmacological development. This challenge is further exacerbated by the lack of comprehensive resources covering its diverse natural components, particularly as most previous research neglected peptides and small RNAs, which possess emerging therapeutic potential. There is an urgent need for novel research models to explore polyherbal formulations such as HXZQ. Here, we present the Huoxiang Zhengqi Component Galaxy (HXZQCG), a dedicated database for the HXZQ. HXZQCG integrates over seven million natural components through artificial intelligence-assisted mining, including 15 811 metabolites, 7 597 212 small peptides, and 152 342 small RNAs. To demonstrate its utility, we applied HXZQCG to screen for ligands of the histamine H

Indexed as

cell membrane chromatographydatabasehistamine H2 receptorHuoxiang Zhengqinatural diverse componentspolyherbal formulation

Identifiers

PMID42948390
PMCPMC13712359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.